ENDRA Life Sciences Inc.
USD5.16
+0.16 (+3.20%)
CEO
Alexander Y. Tokman
IPO Date
2017-06-30
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$5.01
Prev. Close
$5.00
Day Low
$4.92
Day High
$5.23
52W Low
$2.96
52W High
$11.96
Market Cap
$0.00B
Volume
0.00M
| -0.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -177.8% | -148.9% | 0.07 | 3.36 | -629.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -182.9% | -142.1% | 0.08 | 5.00 | -1043.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -104.1% | -87.2% | 0.07 | 7.83 | -4411.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -163.6% | -133.8% | 0.11 | 8.32 | -2148.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -279.5% | -185.4% | 0.16 | 3.15 | -1657.1 |
| 31 Dec 2018 | FY | 100.0% | -158669.6% | -156.8% | -135.6% | 0.00 | 7.13 | -1207.1 |
| 31 Dec 2017 | FY | 50.9% | -1529.2% | -101.9% | -87.8% | 0.00 | 6.93 | -6193.0 |
| 31 Dec 2016 | FY | 54.3% | -538.3% | 310.5% | -565.5% | -1.06 | 0.14 | -9607.9 |
| -0.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -931.2% | -81.3% | 3.07 | 1.31 | -0.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -83.2% | -43.7% | 0.38 | 3.21 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -59.1% | -32.7% | 0.34 | 3.85 | -0.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -162.0% | -93.2% | 0.23 | 5.67 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -35.6% | -28.1% | 0.07 | 6.10 | -0.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -24.8% | -21.3% | 0.06 | 4.97 | -31.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -75.1% | -54.8% | 0.11 | 1.04 | -108.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -25.8% | -21.6% | 0.07 | 3.36 | -1085.4 |